March 3, 2026Open Access

Sustained persistence of blockade antibodies against emerging GII.4 and GII.17 noroviruses revealed by a 5-year community-based serological study

Key Points

Antibody responses against GII.4 and GII.17 noroviruses persist for at least five years, highlighting the durability of immunity.
Significant contrast exists between GII immunity and transient GI immunity, marking a crucial advancement in immunology.
Longitudinal data highlights the robustness of functional antibody responses following natural infections with these genogroups.
The findings pave the path for developing effective, long-lasting vaccines against noroviruses using these insights.

Abstract

This study provides the first longitudinal evidence that natural infection with major GII NoVs, particularly GII.4 and the emerging GII.17, elicits robust and sustained functional antibody responses that persist for at least five years. This fundamental genogroup-specific disparity in immune durability, contrasting sharply with transient GI immunity, reveals a new dimension of NoVs immunology and provides a critical evidence base for the design of effective, long-lasting vaccines.

Bookmark

View Full Paper

Cite This Study

Xie et al. (Tue,) studied this question.

synapsesocial.com/papers/69a75a84c6e9836116a206f1 https://doi.org/https://doi.org/10.3389/fcimb.2026.1734113

Bookmark

View Full Paper